Live Breaking News & Updates on Pieris pharmaceuticals

Stay informed with the latest breaking news from Pieris pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pieris pharmaceuticals and stay connected to the pulse of your community

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ:PIRS opened at $12.04 on Friday. Pieris Pharmaceuticals has a twelve month low of $10.89 and a […]

Boston , Massachusetts , United-states , Les-laboratoires-servier , Recherches-internationales-servier , Pfizer-inc , News-ratings-for-pieris-pharmaceuticals-daily , Nasdaq , Pieris-pharmaceuticals-stock-performance , Acadian-asset-management , Boston-pharmaceuticals , Pieris-pharmaceuticals

Pieris Pharmaceuticals (NASDAQ:PIRS) Shares Gap Down to $12.00

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $12.00, but opened at $11.71. Pieris Pharmaceuticals shares last traded at $11.30, with a volume of 14,761 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com initiated coverage on shares of […]

Boston , Massachusetts , United-states , Recherches-internationales-servier , Les-laboratoires-servier , Boston-pharmaceuticals , Cm-management , Pfizer-inc , Pieris-pharmaceuticals-inc , News-ratings-for-pieris-pharmaceuticals-daily , Pieris-pharmaceuticals-stock-performance , Pieris-pharmaceuticals

Pieris Pharmaceuticals (NASDAQ:PIRS) Shares Gap Down to $12.00

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $12.00, but opened at $11.71. Pieris Pharmaceuticals shares last traded at $11.30, with a volume of 14,761 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com started coverage on Pieris […]

Boston , Massachusetts , United-states , Les-laboratoires-servier , Recherches-internationales-servier , Boston-pharmaceuticals , Hedge-funds-weigh-in-on-pieris-pharmaceuticals , Pieris-pharmaceuticals , Nasdaq , Cm-management , Pieris-pharmaceuticals-company-profile , Pfizer-inc

Pieris Pharmaceuticals (NASDAQ:PIRS) Shares Gap Down to $12.00

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $12.00, but opened at $11.71. Pieris Pharmaceuticals shares last traded at $11.30, with a volume of 14,761 shares traded. Wall Street Analysts Forecast Growth Separately, StockNews.com started coverage on Pieris […]

Boston , Massachusetts , United-states , Les-laboratoires-servier , Recherches-internationales-servier , Boston-pharmaceuticals , Pfizer-inc , Pieris-pharmaceuticals-stock-performance , Pieris-pharmaceuticals , Pieris-pharmaceuticals-company-profile , News-ratings-for-pieris-pharmaceuticals-daily , Hedge-funds-weigh-in-on-pieris-pharmaceuticals

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $0.15 on Friday. Pieris Pharmaceuticals has a one year low […]

Boston , Massachusetts , United-states , Recherches-internationales-servier , Les-laboratoires-servier , Pieris-pharmaceuticals-stock-performance , Securities-exchange-commission , Pfizer-inc , Boston-pharmaceuticals , Nasdaq , Cm-management , Pieris-pharmaceuticals

Pieris Pharmaceuticals (NASDAQ:PIRS) Sees Large Volume Increase

Shares of Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Get Free Report) saw unusually-strong trading volume on Tuesday . Approximately 31,577 shares traded hands during trading, an increase of 316% from the previous session’s volume of 7,598 shares.The stock last traded at $11.65 and had previously closed at $11.69. Analyst Ratings Changes Separately, StockNews.com initiated coverage on […]

Boston , Massachusetts , United-states , Recherches-internationales-servier , Les-laboratoires-servier , News-ratings-for-pieris-pharmaceuticals-daily , Boston-pharmaceuticals , Pfizer-inc , Nasdaq , Pieris-pharmaceuticals-company-profile , Pieris-pharmaceuticals , Pieris-pharmaceuticals-inc

Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split

BOSTON, MA - Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be...

Boston , Massachusetts , United-states , Nevada , Securities-exchange , Computershare-trust-company , Company-quarterly-reports-on-form , Exchange-commission , Boston-pharmaceuticals , Pieris-pharmaceuticals-inc , Pieris-pharmaceuticals

Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of PIRS stock opened at $0.15 on Friday. The business’s fifty day moving average price is […]

Boston , Massachusetts , United-states , Recherches-internationales-servier , Les-laboratoires-servier , News-ratings-for-pieris-pharmaceuticals-daily , Topco-ltd , Pfizer-inc , Tower-research-capital , Pieris-pharmaceuticals-inc , Boston-pharmaceuticals , Oppenheimer-co

Analysts' New Coverage for April 21st (AMPE, APDN, BKCC, BKSC, BLIN, BYFC, CMCT, CPE, CVLY, DIT)

Analysts' New Coverage for April 21st (AMPE, APDN, BKCC, BKSC, BLIN, BYFC, CMCT, CPE, CVLY, DIT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , South-carolina , Ampio-pharmaceuticals , Global-indemnity-group , Creative-media-community-trust-co , Codorus-valley-bancorp , Pieris-pharmaceuticals , Nustar-energy , Union-bankshares , Ampio-pharmaceuticals-inc , Callon-petroleum

Pieris Pharma (PIRS) Announces 1-for-80 Reverse Stock Split

Pieris Pharma (PIRS) Announces 1-for-80 Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nevada , United-states , Pieris-pharmaceuticals-inc , Computershare-trust-company , Nasdaq , Pieris-pharmaceuticals , Eastern-time , Nasdaq-capital-market , Nasdaq-capital , Nevada-secretary , Trust-company